×
Volver a Agenda
LS30: Paradigm Shift of Clinical Trial Site Costs ~Effort to Address the Diversifying Changes in Clinical Trial Design~
Session Chair(s)
Kenji Udo
Group Lead of Clinical Operations
Pfizer R&D Japan G.K., Japan
Speaker(s)
Toshiyuki Okada
Astellas Pharma Inc., Japan
Director, Clinical Operating Model, Strategic Business Operations and Execution
Keiichi Inaizumi, MSc
Pfizer R&D Japan, Japan
Clinical Study Innovation Lead, Clinical Project Management Group
¿Tiene una cuenta?